A bactericidal #tuberculosis drug regimen driven by inhibition of the terminal oxidases by #pretomanid -> doi.org/10.1038/s44321-026-00378-9
By N. Ab Rahman, K. Pethe & colleagues at Nanyang Technological University, National Centre for Infectious Diseases & @ineosoxford.bsky.social
Breakthrough Data on Pediatric Use of Pretomanid for Drug-Resistant Tuberculosis Unveiled at 2025 Union Conference #Denmark #Copenhagen #pretomanid #RR-TB #IMPAACT
Read the Journal of #Infection for the study assessing the effectiveness of #bedaquiline, #pretomanid and #linezolid regimens with varying doses and duration of #linezolid at the end of 48 weeks post treatment among drug resistant #tuberculosis patients π www.journalofinfecti...
Significant Price Reduction for DR-TB Drug Marks Progress in Global Health Access #United_States #New_York #TB_Alliance #pretomanid #drug-resistant_TB
π Leading TB experts call for an urgent expansion of the European Medicines Agency label for #Pretomanid, a key drug against drug-resistant #tuberculosis.
The goal: Better access to more effective treatments in line with @who.int guidance #WorldTBDay #YesWeCanEndTB
π www.dzif.de/en/open-lett...
In a positive step for access to #EssentialMedicinesπ for #tuberculosis in Canada, the process for accessing #pretomanid has been simplified (though it remains unmarketed in Canada). www.stoptbcanada.com/news/improve...